In-silico Evaluation of Bioactive Compounds from Tea As Potential SARS-CoV-2 Nonstructural Protein 16 Inhibitors

Overview

Journal J Tradit Complement Med

Specialty Rehabilitation Medicine

Date 2021 Jun 8

PMID 34099976

Citations 53

Authors

Rahul Singh

Vijay Kumar Bhardwaj

Jatin Sharma

Rituraj Purohit

Sanjay Kumar

Affiliations

Soon will be listed here.

Abstract

Background And Aim: A novel coronavirus, called the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been found to cause COVID-19 in humans and some other mammals. The nonstructural protein 16 (NSP16) of SARS-CoV-2 plays a significant part in the replication of viruses and suppresses the ability of innate immune system to detect the virus. Therefore, inhibiting NSP16 can be a secure path towards identifying a potent medication against SARS-CoV-2. Tea () polyphenols have been reported to exhibit potential treatment options against various viral diseases.

Methods: We conducted molecular docking and structural dynamics studies with a set of 65 Tea bioactive compounds to illustrate their ability to inhibit NSP16 of SARS-CoV-2. Moreover, post-simulations end state thermodynamic free energy calculations were estimated to strengthen our results.

Results And Conclusion: Six bioactive tea molecules showed better docking scores than the standard molecule sinefungin. These results were further validated by MD simulations, where Theaflavin compound demonstrated lower binding free energy in comparison to the standard molecule sinefungin. The compound theaflavin could be considered as a novel lead compound for further evaluation by and studies.

Citing Articles

Predictive Insights Into Bioactive Compounds from Streptomyces as Inhibitors of SARS-CoV-2 Mutant Strains by Receptor Binding Domain: Molecular Docking and Dynamics Simulation Approaches.

Kalhor H, Mokhtarian M, Rahimi H, Shahbazi B, Kalhor R, Komeili Movahed T Iran J Pharm Res. 2025; 23(1):e150879.

PMID: 40066112 PMC: 11892749. DOI: 10.5812/ijpr-150879.

Investigating small molecules in propolis as Nipah virus glycoprotein (NiV-G) inhibitors through molecular interaction studies.

Faruque M, Siraj M, Zilani M, Das A, Anisuzzman M, Islam M Heliyon. 2025; 11(4):e42595.

PMID: 40051842 PMC: 11883394. DOI: 10.1016/j.heliyon.2025.e42595.

Tannic acids and proanthocyanidins in tea inhibit SARS-CoV-2 variants infection.

Chen C, Wang W, Wu C, Wang S, Chang W, Hung M Am J Cancer Res. 2024; 14(5):2555-2569.

PMID: 38859869 PMC: 11162682. DOI: 10.62347/QJBG3026.

Potential anti-hyperglycemic activity of black tea theaflavins through inhibiting α-amylase.

Li M, Dong Y, Kang M, Tao T, Li W, Zhang S Food Chem X. 2024; 22:101296.

PMID: 38550892 PMC: 10972827. DOI: 10.1016/j.fochx.2024.101296.

Evaluation of NO-Sartans against SARS-CoV-2.

Omidkhah N, Hadizadeh F, Ghodsi R, Kesharwani P, Sahebkar A Curr Drug Discov Technol. 2024; 21(6):e050324227669.

PMID: 38445698 DOI: 10.2174/0115701638279362240223070810.

References

Huang K, Luo S, Cong Y, Zhong S, Zhang J, Duan L . An accurate free energy estimator: based on MM/PBSA combined with interaction entropy for protein-ligand binding affinity. Nanoscale. 2020; 12(19):10737-10750. DOI: 10.1039/c9nr10638c. View

Zheng J, Frisch M . Efficient Geometry Minimization and Transition Structure Optimization Using Interpolated Potential Energy Surfaces and Iteratively Updated Hessians. J Chem Theory Comput. 2017; 13(12):6424-6432. DOI: 10.1021/acs.jctc.7b00719. View

Bhardwaj V, Purohit R . A new insight into protein-protein interactions and the effect of conformational alterations in PCNA. Int J Biol Macromol. 2020; 148:999-1009. DOI: 10.1016/j.ijbiomac.2020.01.212. View

Krafcikova P, Silhan J, Nencka R, Boura E . Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin. Nat Commun. 2020; 11(1):3717. PMC: 7381658. DOI: 10.1038/s41467-020-17495-9. View

Liang J, Pitsillou E, Burbury L, Hung A, Karagiannis T . In silico investigation of potential small molecule inhibitors of the SARS-CoV-2 nsp10-nsp16 methyltransferase complex. Chem Phys Lett. 2021; 774:138618. PMC: 8032478. DOI: 10.1016/j.cplett.2021.138618. View

Decroly E, Debarnot C, Ferron F, Bouvet M, Coutard B, Imbert I . Crystal structure and functional analysis of the SARS-coronavirus RNA cap 2'-O-methyltransferase nsp10/nsp16 complex. PLoS Pathog. 2011; 7(5):e1002059. PMC: 3102710. DOI: 10.1371/journal.ppat.1002059. View

Kumari R, Kumar R, Lynn A . g_mmpbsa--a GROMACS tool for high-throughput MM-PBSA calculations. J Chem Inf Model. 2014; 54(7):1951-62. DOI: 10.1021/ci500020m. View

Chen Y, Su C, Ke M, Jin X, Xu L, Zhang Z . Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex. PLoS Pathog. 2011; 7(10):e1002294. PMC: 3192843. DOI: 10.1371/journal.ppat.1002294. View

Karplus M, Kuriyan J . Molecular dynamics and protein function. Proc Natl Acad Sci U S A. 2005; 102(19):6679-85. PMC: 1100762. DOI: 10.1073/pnas.0408930102. View

10.

Sevajol M, Subissi L, Decroly E, Canard B, Imbert I . Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus. Virus Res. 2014; 194:90-9. PMC: 7114481. DOI: 10.1016/j.virusres.2014.10.008. View

11.

van der Spoel D, Lindahl E, Hess B, Groenhof G, Mark A, Berendsen H . GROMACS: fast, flexible, and free. J Comput Chem. 2005; 26(16):1701-18. DOI: 10.1002/jcc.20291. View

12.

Aouadi W, Blanjoie A, Vasseur J, Debart F, Canard B, Decroly E . Binding of the Methyl Donor -Adenosyl-l-Methionine to Middle East Respiratory Syndrome Coronavirus 2'--Methyltransferase nsp16 Promotes Recruitment of the Allosteric Activator nsp10. J Virol. 2016; 91(5). PMC: 5309940. DOI: 10.1128/JVI.02217-16. View

13.

Encinar J, Menendez J . Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2'-O-Methylation of Viral RNA. Viruses. 2020; 12(5). PMC: 7291090. DOI: 10.3390/v12050525. View

14.

Chowdhury P, Barooah A . Tea Bioactive Modulate Innate Immunity: In Perception to COVID-19 Pandemic. Front Immunol. 2020; 11:590716. PMC: 7655931. DOI: 10.3389/fimmu.2020.590716. View

15.

Prasansuklab A, Theerasri A, Rangsinth P, Sillapachaiyaporn C, Chuchawankul S, Tencomnao T . Anti-COVID-19 drug candidates: A review on potential biological activities of natural products in the management of new coronavirus infection. J Tradit Complement Med. 2021; 11(2):144-157. PMC: 7833040. DOI: 10.1016/j.jtcme.2020.12.001. View

16.

Rangsinth P, Sillapachaiyaporn C, Nilkhet S, Tencomnao T, Ung A, Chuchawankul S . Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An approach. J Tradit Complement Med. 2021; 11(2):158-172. PMC: 7836338. DOI: 10.1016/j.jtcme.2020.12.002. View

17.

Hansson T, Oostenbrink C, van Gunsteren W . Molecular dynamics simulations. Curr Opin Struct Biol. 2002; 12(2):190-6. DOI: 10.1016/s0959-440x(02)00308-1. View

18.

Schuttelkopf A, van Aalten D . PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr. 2004; 60(Pt 8):1355-63. DOI: 10.1107/S0907444904011679. View

19.

Vardhan S, Sahoo S . Virtual screening by targeting proteolytic sites of furin and TMPRSS2 to propose potential compounds obstructing the entry of SARS-CoV-2 virus into human host cells. J Tradit Complement Med. 2021; 12(1):6-15. PMC: 8040387. DOI: 10.1016/j.jtcme.2021.04.001. View

20.

Salmaso V, Moro S . Bridging Molecular Docking to Molecular Dynamics in Exploring Ligand-Protein Recognition Process: An Overview. Front Pharmacol. 2018; 9:923. PMC: 6113859. DOI: 10.3389/fphar.2018.00923. View